MedPath

Fibrinogen to Albumin Ratio and C-reactive Protein to Albumin Ratio in Juvenile Idiopathic Arthritis

Not yet recruiting
Conditions
Juvenile Idiopathic Arthritis
Interventions
Diagnostic Test: fibrinogen to albumin ratio (AFR) and C-reactive protein to albumin ratio (CAR)
Registration Number
NCT06024486
Lead Sponsor
Assiut University
Brief Summary

The fibrinogen to albumin ratio (FAR) and C-reactive protein to albumin ratio (CAR) have emerged as useful biomarkers to predict systemic inflammation. The aim here is to investigate the relation between FAR/CAR and Juvenile arthritis disease activity score (JASDAS27) in Juvenile idiopathic arthritis (JIA)

Detailed Description

The JADAS27 includes a selected count of the following joints: cervical spine, elbows, wrists, metacarpophalangeal joints (from first to third), proximal interphalangeal joints, hips, knees and ankles.

Recruitment & Eligibility

Status
NOT_YET_RECRUITING
Sex
All
Target Recruitment
50
Inclusion Criteria
  • All juvenile idiopathic arthritis fulfilling the criteria of International League of Associations for Rheumatology (ILAR) and age and sex matched healthy subjects
Exclusion Criteria
  • Other systemic inflammatory or autoimmune disorders.
  • History of corticosteroid medication in the last 6 months.
  • Liver diseases.
  • Malignancy.

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Arm && Interventions
GroupInterventionDescription
CONTROLfibrinogen to albumin ratio (AFR) and C-reactive protein to albumin ratio (CAR)age and sex matched healthy controls
JIA casesfibrinogen to albumin ratio (AFR) and C-reactive protein to albumin ratio (CAR)juvenile idiopathic arthritis cases
Primary Outcome Measures
NameTimeMethod
Correlation of fibrinogen to albumin and CRP to albumin ratios on one side with disease activity on the other side3 MONTHS

correlation of these ratios with JADAS27

The CRP to albumin ratio3 MONTHS

measurement of serum CRP and albumin

The fibrinogen to albumin ratio3 months

measurement of serum fibrinogen and albumin

Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath